199 related articles for article (PubMed ID: 33628817)
1. Using Elevated Cholesterol Synthesis as a Prognostic Marker in Wilms' Tumor: A Bioinformatic Analysis.
He Y; Cui X; Lin Y; Wang Y; Wu D; Fang Y
Biomed Res Int; 2021; 2021():8826286. PubMed ID: 33628817
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms' Tumor.
Zheng H; Li BH; Liu C; Jia L; Liu FT
Biomed Res Int; 2020; 2020():4951692. PubMed ID: 32149111
[TBL] [Abstract][Full Text] [Related]
3. Multidimensional Transcriptomics Unveils RNF34 as a Prognostic Biomarker and Potential Indicator of Chemotherapy Sensitivity in Wilms' Tumour.
Zheng J; Liu F; Tuo J; Chen S; Su J; Ou X; Ding M; Chen H; Shi B; Li Y; Chen X; Wang C; Su C
Mol Biotechnol; 2024 May; 66(5):1132-1143. PubMed ID: 38195816
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological parameters and prognostic relevance of miR-21 and PTEN expression in Wilms' tumor.
Cui M; Liu W; Zhang L; Guo F; Liu Y; Chen F; Liu T; Ma R; Wu R
J Pediatr Surg; 2017 Aug; 52(8):1348-1354. PubMed ID: 28040201
[TBL] [Abstract][Full Text] [Related]
5. Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.
Wang X; Du G; Wu Y; Zhang Y; Guo F; Liu W; Wu R
Int J Oncol; 2020 Feb; 56(2):568-580. PubMed ID: 31894270
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of a Long Noncoding RNA-Associated Competing Endogenous RNA Network in Wilms Tumor.
Zhang F; Zeng L; Cai Q; Xu Z; Liu R; Zhong H; Mukiibi R; Deng L; Tang X; Xin H
Cancer Control; 2020; 27(2):1073274820936991. PubMed ID: 32597194
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
[TBL] [Abstract][Full Text] [Related]
8. A novel pyroptosis-related gene signature exhibits distinct immune cells infiltration landscape in Wilms' tumor.
Guo Y; Lu W; Zhang Z; Liu H; Zhang A; Zhang T; Wu Y; Li X; Yang S; Cui Q; Li Z
BMC Pediatr; 2024 Apr; 24(1):279. PubMed ID: 38678251
[TBL] [Abstract][Full Text] [Related]
9. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
[TBL] [Abstract][Full Text] [Related]
10. Weighted gene co‑expression network analysis for identifying hub genes in association with prognosis in Wilms tumor.
Wang X; Song P; Huang C; Yuan N; Zhao X; Xu C
Mol Med Rep; 2019 Mar; 19(3):2041-2050. PubMed ID: 30664180
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma: What now?
Valind A; Gisselsson D
Cancer Rep (Hoboken); 2021 Dec; 4(6):e1397. PubMed ID: 33932141
[TBL] [Abstract][Full Text] [Related]
12. Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.
Natrajan R; Reis-Filho JS; Little SE; Messahel B; Brundler MA; Dome JS; Grundy PE; Vujanic GM; Pritchard-Jones K; Jones C
Cancer Res; 2006 Dec; 66(23):11148-55. PubMed ID: 17145858
[TBL] [Abstract][Full Text] [Related]
13. Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
Qi C; Hu Y; Yang F; An H; Zhang J; Jin H; Guo F
J Pediatr Surg; 2016 Sep; 51(9):1501-6. PubMed ID: 27230801
[TBL] [Abstract][Full Text] [Related]
14. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
[TBL] [Abstract][Full Text] [Related]
15. Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors.
Natrajan R; Little SE; Reis-Filho JS; Hing L; Messahel B; Grundy PE; Dome JS; Schneider T; Vujanic GM; Pritchard-Jones K; Jones C
Clin Cancer Res; 2006 Dec; 12(24):7284-93. PubMed ID: 17189400
[TBL] [Abstract][Full Text] [Related]
16. Identification of a five-mRNA signature as a novel potential prognostic biomarker in pediatric Wilms tumor.
Lin XD; Wu YP; Chen SH; Sun XL; Ke ZB; Chen DN; Li XD; Lin YZ; Wei Y; Zheng QS; Xu N; Xue XY
Mol Genet Genomic Med; 2020 Jan; 8(1):e1032. PubMed ID: 31701684
[TBL] [Abstract][Full Text] [Related]
17. Decreased E-cadherin expression correlates with higher stage of Wilms' tumors.
Safford SD; Freemerman AJ; Langdon S; Bentley R; Goyeau D; Grundy PE; Skinner MA
J Pediatr Surg; 2005 Feb; 40(2):341-8. PubMed ID: 15750927
[TBL] [Abstract][Full Text] [Related]
18. Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.
Ortiz MV; Ahmed S; Burns M; Henssen AG; Hollmann TJ; MacArthur I; Gunasekera S; Gaewsky L; Bradwin G; Ryan J; Letai A; He Y; Naranjo A; Chi YY; LaQuaglia M; Heaton T; Cifani P; Dome JS; Gadd S; Perlman E; Mullen E; Steen H; Kentsis A
JCI Insight; 2019 Aug; 4(15):. PubMed ID: 31391345
[TBL] [Abstract][Full Text] [Related]
19. Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor.
Re GG; Willingham MC; el Bahtimi R; Brownlee NA; Hazen-Martin DJ; Garvin AJ
Mod Pathol; 1997 Feb; 10(2):129-36. PubMed ID: 9127318
[TBL] [Abstract][Full Text] [Related]
20. [Expression of the neurotrophin-receptor TrkB predicts outcome in nephroblastomas: results of a pilot-study].
Eggert A; Grotzer MA; Zhao H; Brodeur GM; Evans AE
Klin Padiatr; 2001; 213(4):191-6. PubMed ID: 11528553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]